TNO is to participate in a Dutch consortium on biomedical materials. The BioMedical Materials consortium (BMM) aims to provide a leadership position to the Netherlands in biomedical materials and will facilitate novel product development for various medical applications. The BMM will use public-private partnerships to fully utilize the strong knowledge base in the Dutch industry and academia.
The consortium has a provisional budget of €120 M over five years and is submitting a business plan to the Dutch government to obtain public funding for the consortium. The BMM intends to initiate research activities among participants in the consortium in the third quarter of 2006 and additionally will utilize potential synergies.
The other participants in the consortium are DSM, Medtronic, Organon, Philips Research, Fortimedix, Fuji-Life Sciences, Innocore, Pharmacell, Pharming Group NV, Polyganics, De Nierstichting, Radboud Universiteit Nijmegen, Rijksuniversiteit Groningen, Technische Universiteit Eindhoven, Universiteit Maastricht, Universiteit Twente and Universiteit Utrecht.
 | |
| |
 | |
|